PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Ronald van Vollenhoven, MD, PhD - Managing Patients with Lupus: When Should We Escalate Treatment?
Visit https://www.peervoice.com/BDT860 to view the entire programme with slides. After completing “Ronald van Vollenhoven, MD, PhD - Managing Patients with Lupus: When Should We Escalate Treatment? ”, participants will be able to: Explain the impact of suboptimal disease control on the progression of systemic lupus erythematosus (SLE); Identify patient and disease characteristics that may influence treatment decision-making in patients with moderate-severe SLE and improve long-term outcomes; Evaluate opportunities to optimise management of patients with moderate-severe SLE; and Apply effective treatment plans to optimise clinical and quality of life (QoL) outcomes for patients with moderate-severe SLE.